Most Read Articles
Rachel Soon, 08 Apr 2020

Guidelines for local pharmacists on what actions to take during the COVID-19 pandemic have been issued by the Malaysian Pharmaceutical Society (MPS).

Elaine Soliven, 20 May 2020
Early treatment with a triple antiviral combination of lopinavir-ritonavir, ribavirin, and interferon beta-1b significantly shortens the duration of virus shedding and reduces symptoms in patients with mild-to-moderate COVID-19 compared with lopinavir-ritonavir only, according to a recent study.
Pearl Toh, 26 Sep 2019
The Singapore Health Sciences Authority (HSA) has recalled eight brands of ranitidine products containing trace amounts of the nitrosamine impurity NDMA*, which is a potential human carcinogen.
Roshini Claire Anthony, 6 days ago

The use of a vaginal cleansing intervention prior to Caesarean delivery reduced the incidence of surgical site infections (SSIs), according to a study presented at ACOG 2020. However, the addition of intravenous (IV) azithromycin prophylaxis had no added impact on SSI rates. 

Multimodal analgesia better than opioids at dulling pain after penile implants

07 Mar 2020

Multimodal analgesia (MMA) regimens effectively decrease postoperative pain in patients receiving inflatable penile prosthesis (IPP) implants, a recent study has found.

The study included 203 patients undergoing IPP implantation, of whom 103 (mean age, 62.9±8.8 years) were given an MMA protocol consisting of preoperative and postoperative doses of acetaminophen, gabapentin, and meloxicam or celecoxib, with intraoperative administrations of dorsal and pudendal nerve blocks. The remaining 100 patients (mean age, 64.3±10.1 years) were set as opioid-only controls.

The MMA regimen appeared to be superior. Median visual analogue scale (VAS) scores were significantly lower relative to the opioid group in the postanaesthesia care unit (PACU; 0.0 vs 2.0; p=0.01) and at postoperative day 0 (3.0 vs 4.0; p=0.001) and day 1 (3.0 vs 4.3; p=0.04).

Similarly, fewer narcotics were needed in the MMA vs the opioid group while in the PACU (0.0 vs 4.0 total morphine equivalents; p=0.001) and at postoperative day 0 (7.5 vs 12.5 total morphine equivalents; p<0.001) and day 1 (7.5 vs 13.5 total morphine equivalents; p=0.01).

These advantages extended until the time of discharge, at which point patients treated with the MMA protocol were prescribed significantly fewer narcotics (p<0.001) and were less likely to need refills (p=0.001) than their opioid comparators.

Both treatments were comparably tolerated, with no pain medication-related side effects reported in either arm. This included manifestations such as visual changes, haematomas and acute kidney injuries. The rates of postoperative urinary retention (8.7 percent vs 12.5 percent; p=0.49) and pruritis (0.9 percent vs 3.1 percent; p=0.35) also did not differ between groups.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Pharmacist - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Rachel Soon, 08 Apr 2020

Guidelines for local pharmacists on what actions to take during the COVID-19 pandemic have been issued by the Malaysian Pharmaceutical Society (MPS).

Elaine Soliven, 20 May 2020
Early treatment with a triple antiviral combination of lopinavir-ritonavir, ribavirin, and interferon beta-1b significantly shortens the duration of virus shedding and reduces symptoms in patients with mild-to-moderate COVID-19 compared with lopinavir-ritonavir only, according to a recent study.
Pearl Toh, 26 Sep 2019
The Singapore Health Sciences Authority (HSA) has recalled eight brands of ranitidine products containing trace amounts of the nitrosamine impurity NDMA*, which is a potential human carcinogen.
Roshini Claire Anthony, 6 days ago

The use of a vaginal cleansing intervention prior to Caesarean delivery reduced the incidence of surgical site infections (SSIs), according to a study presented at ACOG 2020. However, the addition of intravenous (IV) azithromycin prophylaxis had no added impact on SSI rates.